Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-06-001569
Filing Date
2006-06-16
Accepted
2006-06-16 15:32:55
Documents
2
Period of Report
2006-06-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3685
2 POWER OF ATTORNEY doc8631.txt EX-24 2843
  Complete submission text file 0001127602-06-001569.txt   8436
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 420 420 CHIPETA WAY SUITE 240 SALT LAKE CITY UT 84108 8015834939
COSTA SANTO J (Reporting) CIK: 0001013419 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 06910190